Abstract:STUDY QUESTION: Do long non-coding RNA (lncRNA) and messenger RNA (mRNA) profiles in follicular fluid from mature and immature ovarian follicles differ between healthy women and women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: lncRNA and mRNA profiles in follicular fluid from both mature and immature ovarian follicles differed significantly between healthy women and PCOS patients. WHAT IS KNOWN ALREADY: Unlike microRNAs, which have been extensively studied, lncRNAs present in follicular fluid have never been sequenced and the biological associations of lncRNAs in healthy follicles and follicles in women who develop PCOS remain largely unknown. STUDY DESIGN, SIZE, DURATION: A total of 18 subjects (8 controls and 10 PCOS patients) were recruited to participate in this study. Recruitment took place from May 2016 to September 2016. PARTICIPANTS/ MATERIALS, SETTING, METHODS: The follicular fluid donors underwent their first round of in-vitro fertilization treatment. Follicle size was determined based on the average follicular diameter, and follicular fluid samples were collected from mature follicles (17-22 mm) and matched-immature follicles (8-13 mm). RNA sequencing was performed on follicular fluids from mature and immature follicles of healthy women and PCOS patients. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 1583 novel lncRNAs were identified in 36 human follicular fluid samples and some were expressed differently in healthy and PCOS women. lncRNAs associated with the metabolic process were highly enriched in the follicular fluid of mature follicles from the PCOS group versus the healthy group. In the PCOS group, nervous system process lncRNAs were highly enriched in the follicular fluid of mature versus immature follicles, whereas in the healthy group, lncRNAs associated with junction adhesion and communication-related processes were highly enriched in the follicular fluid of mature versus immature follicles. In addition, differentially expressed mRNAs were principally linked to olfactory transduction pathways. Consistent results from Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) indicated that telomere maintenance and MAPK and Wnt pathways may be conserved processes, active in follicular development, and monosaccharide biosynthesis might provide possible pathway markers to distinguish between normal and PCOS follicles. We constructed gene co-expression networks that identified many co-regulatory relationships among follicular fluid lncRNAs, mRNAs, and PCOS phenotypes. Weighted Gene Co-expression Network Analysis (WGCNA) revealed lncRNAs and mRNAs that were core and others associated with the PCOS phenotype. LIMITATIONS, REASONS FOR CAUTION: It remains unclear whether these differential transcripts contribute directly to follicular development or the pathogenesis of PCOS, or are merely biomarkers. WIDER IMPLICATIONS OF THE FINDINGS: It will be important in the future for investigators to ascertain the biologic mechanisms underlying the development of both normal and PCOS follicles. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (No. 81671423, No. 81402130 and No. 81501247), the Fok Ying Tung Education Foundation (No. 151039), and Distinguished Talent Program of Shengjing Hospital (No. ME76). No competing interests declared.

Identification of small extracellular vesicle-linked miRNA specifically derived from intrafollicular cells in women with polycystic ovary syndrome

Ovarian Leukocyte Distribution and Cytokine/chemokine Mrna Expression in Follicular Fluid Cells in Women with Polycystic Ovary Syndrome.

Extraction and identification of exosomes in follicular fluid from patients with polycystic ovary syndrome and isolation and detection of miRNAs in exosomes

Identification of microRNAs in human follicular fluid: characterization of microRNAs that govern steroidogenesis in vitro and are associated with polycystic ovary syndrome in vivo.

High throughput microRNAs sequencing profile of serum exosomes in women with and without polycystic ovarian syndrome

Differential Expression Profile of Plasma Exosomal Micrornas in Women with Polycystic Ovary Syndrome

Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome

Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

Peptidomic analysis of follicular fluid in patients with polycystic ovarian syndrome

Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.

Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome

Characterization of Microrna Profile in Human Cumulus Granulosa Cells: Identification of Micrornas That Regulate Notch Signaling and Are Associated with PCOS

Depletion of exosomal circLDLR in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in polycystic ovary syndrome

Circulating Micrornas in Patients with Polycystic Ovary Syndrome.

Characterization of altered microRNAs related to different phenotypes of polycystic ovarian syndrome (PCOS) in serum, follicular fluid, and cumulus cells

The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome

Follicular Fluid-Derived Exosomal Mir-143-3p/mir-155-5p Regulate Follicular Dysplasia by Modulating Glycolysis in Granulosa Cells in Polycystic Ovary Syndrome

Molecular Features of Polycystic Ovary Syndrome Revealed by Transcriptome Analysis of Oocytes and Cumulus Cells

Exosomal Circ_0008285 in Follicle Fluid Regulates the Lipid Metabolism Through the Mir-4644/ LDLR Axis in Polycystic Ovary Syndrome

The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome